Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

NIH scientists highlight the urgent need for universal coronavirus vaccines

NIH scientists highlight the urgent need for universal coronavirus vaccines

KHN’s ‘What the Health?’: Oh, oh, omicron

KHN’s ‘What the Health?’: Oh, oh, omicron

New study demonstrates SARS-CoV-2 Omicron antibody escape

New study demonstrates SARS-CoV-2 Omicron antibody escape

Moderna booster vaccination overcomes SARS-CoV-2 Omicron variant antibody escape

Moderna booster vaccination overcomes SARS-CoV-2 Omicron variant antibody escape

Study suggests convalescent plasma appears safe but does not prevent SARS-CoV-2 infection

Study suggests convalescent plasma appears safe but does not prevent SARS-CoV-2 infection

Study details the effectiveness of face masks to reduce the spread of respiratory infections

Study details the effectiveness of face masks to reduce the spread of respiratory infections

Therapeutic antibodies deemed ineffective against Omicron variant of SARS-CoV-2

Therapeutic antibodies deemed ineffective against Omicron variant of SARS-CoV-2

Capability of BNT162b2 vaccine given in 2 or 3 doses to neutralize SARS-CoV-2 Omicron

Capability of BNT162b2 vaccine given in 2 or 3 doses to neutralize SARS-CoV-2 Omicron

Experimental and computational synergy considered a promising approach in COVID-19 patients

Experimental and computational synergy considered a promising approach in COVID-19 patients

T cell responses remain broadly robust against Omicron variant of SARS-CoV-2

T cell responses remain broadly robust against Omicron variant of SARS-CoV-2

Neutralization potency of COVID-19 vaccine boosters against SARS-CoV-2 variant pseudoviruses

Neutralization potency of COVID-19 vaccine boosters against SARS-CoV-2 variant pseudoviruses

Human monoclonal antibody protects against SARS-CoV-2 and SARS-CoV in vivo

Human monoclonal antibody protects against SARS-CoV-2 and SARS-CoV in vivo

Exploring the plasma neutralization properties of the Omicron variant of SARS-CoV-2

Exploring the plasma neutralization properties of the Omicron variant of SARS-CoV-2

Study suggests Omicron can be neutralized by BNT162b2 recipient sera optimally after three vaccine doses

Study suggests Omicron can be neutralized by BNT162b2 recipient sera optimally after three vaccine doses

Nurses in crisis over covid dig in for better work conditions

Nurses in crisis over covid dig in for better work conditions

Covid shots for kids are scarce — and demand is mixed — in rural Montana

Covid shots for kids are scarce — and demand is mixed — in rural Montana

After ‘truly appalling’ death toll in nursing homes, California rethinks their funding

After ‘truly appalling’ death toll in nursing homes, California rethinks their funding

Vaccine effectiveness of mRNA-1273 during the emergence of the SARS-CoV-2 Delta variant

Vaccine effectiveness of mRNA-1273 during the emergence of the SARS-CoV-2 Delta variant

Research provides reassuring data on the risk of heart inflammation after SARS-CoV-2 vaccination

Research provides reassuring data on the risk of heart inflammation after SARS-CoV-2 vaccination

Omicron is more transmissible but may have milder symptoms for many people, expert says

Omicron is more transmissible but may have milder symptoms for many people, expert says

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.